CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00614432
NCT00614432N/ACompleted

Blood Loss at the Time of First Trimester Surgical Abortion in Anticoagulated Women

University of Hawaii·observational·Posted Feb 13, 2008·Updated Jul 18, 2022

In Brief

An observational study for Blood Loss. Completed, enrolled 10 participants across 2 sites.

Detailed Summary

The primary objective of this study is to compare blood loss resulting from surgical termination of pregnancy up to 12 weeks gestation between women who are anticoagulated to therapeutic levels and those who are not anticoagulated. This study is based on the hypothesis that anticoagulant therapy does not increase intraoperative blood loss in women receiving surgical abortions up to 12 weeks gestation.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBlood Loss
CountriesUnited States

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 13, 2008
Enrollment StartJan 1, 2008
Primary CompletionApr 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 18.4 years ago